ZENEFOST Trademark

Trademark Overview


On Thursday, October 26, 2017, a trademark application was filed for ZENEFOST with the United States Patent and Trademark Office. The USPTO has given the ZENEFOST trademark a serial number of 87661562. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 17, 2021. This trademark is owned by Eli Lilly and Company. The ZENEFOST trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use i...
zenefost

General Information


Serial Number87661562
Word MarkZENEFOST
Filing DateThursday, October 26, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 17, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 13, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, November 5, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, May 17, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 17, 2021ABANDONMENT - NO USE STATEMENT FILED
Friday, October 9, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 8, 2020EXTENSION 5 GRANTED
Monday, September 21, 2020EXTENSION 5 FILED
Monday, September 21, 2020TEAS EXTENSION RECEIVED
Saturday, March 21, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 19, 2020EXTENSION 4 GRANTED
Thursday, March 19, 2020EXTENSION 4 FILED
Thursday, March 19, 2020TEAS EXTENSION RECEIVED
Thursday, September 26, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 24, 2019EXTENSION 3 GRANTED
Tuesday, September 24, 2019EXTENSION 3 FILED
Tuesday, September 24, 2019TEAS EXTENSION RECEIVED
Friday, March 1, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 27, 2019EXTENSION 2 GRANTED
Wednesday, February 27, 2019EXTENSION 2 FILED
Wednesday, February 27, 2019TEAS EXTENSION RECEIVED
Thursday, October 18, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 17, 2018EXTENSION 1 GRANTED
Monday, September 24, 2018EXTENSION 1 FILED
Tuesday, October 2, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 24, 2018TEAS EXTENSION RECEIVED
Tuesday, April 10, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 13, 2018PUBLISHED FOR OPPOSITION
Wednesday, January 24, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 3, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 3, 2018ASSIGNED TO EXAMINER
Sunday, November 5, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, October 30, 2017NEW APPLICATION ENTERED IN TRAM